(Joshi, et al., 2023) (Hulst et al., 2021)
One significant advantage of GLP-1 agonists, including semaglutide, over earlier generations of diabetes drugs is their minimal risk of causing hypoglycemia (Collins & Costello, 2023)
Importantly, GLP-1 loses its inhibitory effect on glucagon secretion when blood glucose levels fall, allowing an appropriate glucagon response to hypoglycaemia
MGF exposure may improve muscle weakness and decrease the loss of motor neurons in murine models of ALS
When a step-up changes the week, the comparison to the dose week before becomes obvious instead of vague
They have a massive catalog but often charge a significant premium for their branding